Unruptured Intracranial Aneurysm Treatment Market
Unruptured Intracranial Aneurysm Treatment Market Overview
The report is titled as ‘Unruptured Intracranial Aneurysm Treatment Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the unruptured intracranial aneurysm treatment market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Unruptured intracranial aneurysm treatment market is expected to grow with significant rate in the near future.
The global unruptured intracranial aneurysm treatment market in 2020 is estimated for more than US$ 1,027.1 Mn and expected to reach a value of US$ 1,937.4 Mn by 2028 with a significant CAGR of 8.3%.
Unruptured Intracranial Aneurysm Treatment Market Dynamics
Unruptured intracranial aneurysm is the leading cause of hemorrhagic stroke which can be so severe that it can lead to coma or even death which is the major driving force of the global unruptured intracranial aneurysm treatment market. For instance, according to Angiology Journal, in United Kingdom 10% to 15% of patients with unruptured intracranial aneurysm die before reaching the hospital.
Further, presence of unruptured intracranial aneurysm in the family history is also another factor responsible for the growth of the global unruptured intracranial aneurysm treatment market. Moreover, increasing healthcare funding by government bodies, is also likely to boost the target market. Additionally, high occurrence of high blood pressure in the individuals will also flourish the target market. Further, advancement in surgical techniques and development of new drugs will also fuel the global unruptured intracranial aneurysm treatment market.
Unruptured Intracranial Aneurysm Treatment Market Segmentation
Unruptured Intracranial Aneurysm Treatment Market Segmentation
By Treatment Method
• Surpass Streamline
• Other
By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
Unruptured Intracranial Aneurysm Treatment Market Pipeline Treatment Overview
The global unruptured intracranial aneurysm treatment market has a drug and a flow diverter in a pipeline which are undergoing clinical trials Aspirin and Surpass Streamline Flow Diverter. For the treatment of pain, inflammation and fever, Aspirin is considered as the most common drug which is used around the globe. Some healthcare experts recommend Aspirin to their patients for the prevention of heart attacks and strokes. Its anti-inflammatory properties may be beneficial for patients with unruptured intracranial aneurysm.
The study was designed in 2018, to test whether there is a measurable reduction in inflammation in walls of unruptured intracranial aneurysm with the use of aspirin which is under the phase 2 clinical trial. Surpass Streamline Flow Diverter is used for the large and giant posterior communicating unruptured intracranial aneurysm as they are located in a very challenging area of the body. The device has gained pre market FDA approval for the treatment of unruptured intracranial aneurysm.
Unruptured Intracranial Aneurysm Treatment Market Competitive Landscape
Some of the key participating players in global unruptured intracranial aneurysm treatment market is Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Sophysa Ltd., MicroPort Scientific Corporation, Orsan Medical Technologies, and Spiegelberg GmbH.
Regional Segmentation
On the basis of region, the unruptured intracranial aneurysm treatment market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
MMC Overview on Unruptured Intracranial Aneurysm Treatment Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Unruptured Intracranial Aneurysm Treatment market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Unruptured Intracranial Aneurysm Treatment
• Advantages of Unruptured Intracranial Aneurysm Treatment
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Unruptured Intracranial Aneurysm Treatment Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Unruptured Intracranial Aneurysm Treatment Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Unruptured Intracranial Aneurysm Treatment Market Snapshot
2.4. Global Unruptured Intracranial Aneurysm Treatment Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Unruptured Intracranial Aneurysm Treatment Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Treatment Method
3.1.2. BPS Analysis, By Treatment Method
3.2. Market Revenue (US$Mn) Forecast, By Treatment Method
3.2.1. Surpass Streamline
3.2.2. Other
3.3. Global Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index, By Treatment Method
4. Global Unruptured Intracranial Aneurysm Treatment Market, By Region
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Region
4.1.2. BPS Analysis, By Region
4.2. Market Revenue (US$Mn) Forecast, By Region
4.2.1. North America
4.2.2. Latin America
4.2.3. Europe
4.2.4. Asia Pacific
4.2.5. Middle East
4.2.6. Africa
4.3. Global Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index, By Region
5. North America Unruptured Intracranial Aneurysm Treatment Market Analysis and Forecast, 2020–2028
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Country
5.1.2. BPS Analysis, By Country
5.2. Market Revenue (US$Mn) Forecast, By Country
5.2.1. U.S. Unruptured Intracranial Aneurysm Treatment Market
5.2.2. Canada Unruptured Intracranial Aneurysm Treatment Market
5.3. North America Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method
5.3.1. Surpass Streamline
5.3.2. Other
5.4. North America Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index
5.4.1. By Country
5.4.2. By Treatment Method
6. Latin America Unruptured Intracranial Aneurysm Treatment Market Analysis and Forecast, 2019–2027
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Country
6.1.2. BPS Analysis, By Country
6.2. Market (US$Mn) Forecast, By Country
6.2.1. Brazil Unruptured Intracranial Aneurysm Treatment Market
6.2.2. Mexico Unruptured Intracranial Aneurysm Treatment Market
6.2.3. Argentina Unruptured Intracranial Aneurysm Treatment Market
6.2.4. Rest of Latin America Unruptured Intracranial Aneurysm Treatment Market
6.3. North America Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method
6.3.1. Surpass Streamline
6.3.2. Other
6.4. North America Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index
6.4.1. By Country
6.4.2. By Treatment Method
7. Europe Unruptured Intracranial Aneurysm Treatment Market Analysis and Forecast, 2020–2028
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market (US$Mn) Forecast, By Country
7.2.1. U.K. Unruptured Intracranial Aneurysm Treatment Market
7.2.2. Germany Unruptured Intracranial Aneurysm Treatment Market
7.2.3. Italy Unruptured Intracranial Aneurysm Treatment Market
7.2.4. France Unruptured Intracranial Aneurysm Treatment Market
7.2.5. Spain Unruptured Intracranial Aneurysm Treatment Market
7.2.6. Russia Unruptured Intracranial Aneurysm Treatment Market
7.2.7. Poland Unruptured Intracranial Aneurysm Treatment Market
7.2.8. BENELUX Unruptured Intracranial Aneurysm Treatment Market
7.2.9. NORDIC Unruptured Intracranial Aneurysm Treatment Market
7.2.10. Rest of Europe Unruptured Intracranial Aneurysm Treatment Market
7.3. North America Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method
7.3.1. Surpass Streamline
7.3.2. Other
7.4. North America Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index
7.4.1. By Country
7.4.2. By Treatment Method
8. Asia Pacific Unruptured Intracranial Aneurysm Treatment Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. China Unruptured Intracranial Aneurysm Treatment Market
8.2.2. India Unruptured Intracranial Aneurysm Treatment Market
8.2.3. Japan Unruptured Intracranial Aneurysm Treatment Market
8.2.4. Australia and New Zealand Unruptured Intracranial Aneurysm Treatment Market
8.2.5. South Korea Unruptured Intracranial Aneurysm Treatment Market
8.2.6. ASEAN Unruptured Intracranial Aneurysm Treatment Market
8.2.7. Rest of Asia Pacific Unruptured Intracranial Aneurysm Treatment Market
8.3. North America Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method
8.3.1. Surpass Streamline
8.3.2. Other
8.4. North America Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index
8.4.1. By Country
8.4.2. By Treatment Method
9. Middle East Unruptured Intracranial Aneurysm Treatment Market, By Region
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. GCC Countries Unruptured Intracranial Aneurysm Treatment Market
9.2.2. Israel Unruptured Intracranial Aneurysm Treatment Market
9.2.3. Oman Unruptured Intracranial Aneurysm Treatment Market
9.2.4. Rest of Middle East Unruptured Intracranial Aneurysm Treatment Market
9.3. North America Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method
9.3.1. Surpass Streamline
9.3.2. Other
9.4. North America Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index
9.4.1. By Country
9.4.2. By Treatment Method
10. Africa Unruptured Intracranial Aneurysm Treatment Market, By Region
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. South Africa Unruptured Intracranial Aneurysm Treatment Market
10.2.2. Egypt Unruptured Intracranial Aneurysm Treatment Market
10.2.3. North Africa Unruptured Intracranial Aneurysm Treatment Market
10.2.4. Rest of Africa Unruptured Intracranial Aneurysm Treatment Market
10.3. North America Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method
10.3.1. Surpass Streamline
10.3.2. Other
10.4. North America Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index
10.4.1. By Country
10.4.2. By Treatment Method
11. Recommendation
11.1. Market Strategy
12. Competitive Landscape
12.1. Competition Dashboard
12.2. List and Company Overview of Global Key Players
12.3. Company Profiles
12.3.1. Medtronic Plc.
12.3.1.1. Company Overview
12.3.1.2. Financial Overview
12.3.1.3. Component Portfolio
12.3.1.4. Key Developments
12.3.1.5. Business Strategies
12.3.2. Codman & Shurtleff, Inc.
12.3.3. Raumedic AG
12.3.4. Sophysa Ltd.
12.3.5. MicroPort Scientific Corporation
12.3.6. Orsan Medical Technologies
12.3.7. Spiegelberg GmbH
13. Acronyms